SuperworthSolventum price to book ratio SOLV
Market value divided by the book value of the company's net assets, since 2024.
- Today, Oct 23, 2026
- 3.0×
- 2-year median
- 3.3×
- Against its 2-year history
- 41st
- percentile: 0 is its lowest day, 100 its highest
- 2-year range
- 2.2× to 4.6×
- Peer median
- 5.3×
Solventum's price to book ratio is 3.0× as of Oct 23, 2026.
That is below its 2-year median of 3.3×, close to the middle of its last 2 years.
Over that time it ranged from 2.2× in Mar 2026 to 4.6× in Mar 2025.
The median for 10 medical instruments and supplies stocks of a similar size is 5.3×.
Price to book ratio over time
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 3.0× | 2.2× | 3.3× |
| 2025 | 2.8× | 2.5× | 4.6× |
| 2024 | 3.6× | 2.2× | 4.4× |
Against its peers
Companies in Medical - Instruments & Supplies nearest Solventum's size, closest first, today.
| Company | Price to book ratio |
|---|---|
| SOLVSolventum | 3.0× |
| PENPenumbra | 8.3× |
| COOCooper Companies | 1.4× |
| ALGNAlign Technology | 2.6× |
| GMEDGlobus Medical | 2.3× |
| PODDInsulet | 7.3× |
| WSTWest Pharmaceutical Services | 9.2× |
| MSAMSA Safety | 5.0× |
| RMDResMed | 5.5× |
| MMSIMerit Medical Systems | 3.3× |
| HAEHaemonetics | 6.4× |
| Peer median | 5.3× |
What the price to book ratio tells you
Market value divided by the accounting value of the company's net assets. Below 1 means the market values the business at less than what it owns on paper.
Book value misses brands, software and people, so asset-light companies always look expensive on it. Most useful for banks and industrials.
More on Solventum
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.